Trials / Completed
CompletedNCT00244452
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Identify effective doses of cetrorelix SR in the treatment of symptoms of endometriosis, describe dose effect relationship and duration of symptom relief
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetrorelix |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2005-10-26
- Last updated
- 2008-03-31
Locations
57 sites across 8 countries: Australia, Belgium, Bulgaria, Germany, Romania, Russia, South Africa, Ukraine
Source: ClinicalTrials.gov record NCT00244452. Inclusion in this directory is not an endorsement.